💡 Dealflow & Startup Spotlight: The AI Deeptech Company Raising $50M

Your Weekly Shortcut to Deeptech Investing—Exclusive Trends & Startup Reports for VCs & Angels in Just 5 Minutes

Feb 06, 2025

∙ Paid

A futuristic horizontal image showcasing AI-driven biotech investment. The image features a high-tech financial dashboard displaying investment data, funding rounds, and deeptech startup analytics. Investors in business attire discuss dealflow insights, while a glowing holographic interface highlights a $50M funding milestone for an AI-powered biotech company. The background features a sleek innovation hub with digital financial charts, molecular structures, and AI-driven healthcare analytics.

🔥 Inside This Week’s Dealflow & Startup Spotlight

One AI-driven biotech startup is making waves—Owkin just raised $50M to revolutionize drug discovery with AI. Investors are betting big on its privacy-preserving federated learning model and strong pharma partnerships.

Why it matters: Owkin is positioned for high growth, strong M&A potential, and a future…

Keep reading with a 7-day free trial

Subscribe to Invest Deeptech to keep reading this post and get 7 days of free access to the full post archives.